A B S T R A C T The ability of 10 
A B S T R A C T The ability of 10 ,M epinephrine or isoproterenol to stimulate cyclic AMP accumulation was decreased in hepatocytes isolated from hyperthyroid (triiodothyronine treated) as compared to euthyroid rats. In the presence of methylisobutylxanthine, epinephrine or isoproterenol-stimulated cyclic AMP accumulation was -65% lower in hyperthyroid as compared with euthyroid rat hepatocytes. The ability of glucagon to stimulate a cyclic AMP response was also decreased in the hyperthyroid state, when assayed in either the absence or presence of a methyl xanthine. The character of the catecholamine-stimulated cyclic AMP response was beta adrenergic in both the hyperand euthyroid states. No evidence for an alpha2 adrenergic mediated component of catecholamine action on cyclic AMP levels was noted. Cyclic AMP phosphodiesterase activity of hepatocyte homogenates was not altered in the hyperthyroid state. Hormone-stimulated, guanine nucleotide-and fluoride-activatable adenylate cyclase activity was reduced in subcellular fractions obtained from hyperthyroid as compared with euthyroid rat hepatocytes. Beta adrenergic receptor binding was reduced -35% and glucagon receptor binding reduced -50% in the hyperthyroid as compared with euthyroid rat hepatocyte membrane fractions. The status of the regulatory components of adenylate cyclase were examined by in vitro treatment of subcellular fractions with cholera toxin. The ability of cholera toxin to modulate adenylate cyclase was not altered by hyperthyroidism. Cholera toxin catalyzed INTRODUCTION Thyroid hormones modulate the ability of catecholamine hormones to act in heart (1-4), fat (5-7), and liver (8) (9) (10) . In heart and fat tissue hypothyroidism blunts, whereas hyperthyroidism potentiates, catecholamine-sensitive responses (1) (2) (3) (4) (5) (6) (7) . Hyperthyroidism has been shown to potentiate the ability of catecholamines to activate rat myocardial phosphorylase a (1, 2) . Epinephrine-stimulated cyclic AMP accumulation and lipolysis of isolated rat fat cells are likewise enhanced in those fat cells from hyperthyroid, as compared with euthyroid animals (7) .
The effects of thyroid hormones on catecholamine action are quite different in liver, as compared to heart or fat tissue. Hypothyroidism dramatically potentiates, rather than blunts, the ability of beta adrenergic hormones to activate phosphorylase a and to stimulate cyclic AMP accumulation (8, 9) . This potentiation of the phosphorylase and cyclic AMP responses noted in hypothyroid rat hepatocytes is selective for the beta adrenergic hormone stimulation and is not observed in stimulation by either alpha adrenergic agonists or glucagon (8) . The basis for this enhanced beta adrenergic stimulation of cyclic AMP and phosphorylase responses of hypothyroid rat hepatocytes appears to be a two-to threefold increase in the steady-state level of beta adrenergic receptors (10) .
Information on the effects of hyperthyroidism on the regulation of hepatic cyclic AMP metabolism or glycogen phosphorylase activity by catecholamines and other hormones is lacking. We have examined the hormone-responsive adenylate cyclase system of hepatocytes from triiodothyronine-treated (hyperthyroid) as compared to control (euthyroid) rats. We find that short-term thyroid hormone administration in vivo acutely modulates the hormone-sensitive adenylate cyclase system of rat hepatocytes at several distinct loci. METHODS Animals. Rats (175-225 g fed female Sprague-Dawley SD strain rats from Taconic Farms, Germantown, N. Y.) were made hyperthyroid by a single injection (subcutaneous administration) of triiodothyronine (0.25 mg/kg body wt) at 48, 24 , and 3 h before death. Control rats were littermates or animals of the same weight as those administered thyroid hormone. Serum triiodothyronine levels were 2.2±0.1 nmol/ liter in control and 9.3±0.1 nmol/liter in triiodothyroninetreated animals. Serum thyroxine levels were 43.5±4.4 nmol/liter in control animals and reduced to <13 nmol/liter in the animals administered triiodothyronine.
Hepatocyte preparation. Hepatocytes were isolated following the procedure of Berry and Friend (11) as described previously (8) . After isolation the rat hepatocytes were incubated in a Krebs-Ringer bicarbonate buffer, pH 7.4, containing 22 mM glucose for 30 min, then washed and resuspended in fresh medium for 20 min for the experiments in plastic tubes (17 X 100 mm, model 55.468, Walter Sarstedt, Inc., Princeton, N. J.) in a total volume of 1 ml and were constantly shaken at 37°C in an orbital water bath operating at 150-200 rpm.
Cyclic AMP accumulation measurements. Hepatocytes were incubated for 20 min as described above and then exposed to a hormone or vehicle and the incubation continued for 1 min, the point of maximal cyclic AMP response. A 0.1-ml aliquot of 2 N HCI was added to terminate the cyclic AMP response. These incubation tubes were then heated in a boiling water bath for 1 min and after cooling were neutralized with NaOH. A 20-gl aliquot was taken from the tube and the cyclic AMP content assayed by a modification of the method of Gilman (12) using the cyclic AMP binding protein extracted from bovine adrenal gland. The free cyclic AMP was separated from the bound cyclic AMP by adsorption on activated charcoal, as suggested by Brown et al. (13) . Subcellular fractionation. Subcellular fractions were prepared from freshly isolated hepatocytes by a modification (10) of Neville's method (14) . Hepatocytes were homogenized in 6 vol of ice-cold 1 mM NaHCOs buffer using a Willems Polytron (Brinkmann Instruments, Inc., Westbury, N. Y.) at setting 5 for 30 s and were then further homogenized by 16 strokes of a precision bore glass Potter-Elvehjem homogenizer (Arthur Thomas Co., Philadelphia, Pa.) fitted with a Teflon pestle operated on a Eberback Con-Torque unit set at maximum running speed. All steps from homogenization to preparation of other subcellular fractions were performed in an ice bath. The homogenate was centrifuged at 1,500 g for 10 min at 4°C to yield a supernatant that was discarded, and a pellet ("pellet-l"). This pellet was resuspended in 30 ml of 1 mM NaHCO8 and homogenized again with 16 strokes of the Potter-Elvehjem homogenizer. This fraction was centrifuged at 1,500 g for 10 min at 4°C. The resulting supernatant was discarded and the pellet ("pellet-2") was resuspended in sufficient 69% (wt/wt) sucrose, 1 mM NaHCO3 to yield precisely 44% sucrose (wt/wt). 10 ml of this mixture were placed into a 13-ml polycarbonate ultracentrifuge tube and gently overlaid with 3 ml of a 42.3% sucrose (wt/wt), 1 mM NaHCO3 solution. The sucrose solutions were checked and adjusted to the indicated density by use of a Zeiss refractometer. The tubes were allowed to stand 30 min at 4°C and then centrifuged at 100,000 g for 2 h at 4°C in a Beckman L-65 ultracentrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) fitted with an SW41-Ti rotor. After centrifugation the float ("Purified membranes") was aspirated, resuspended in 1 mM NaHCO3, centrifuged at 12,000 g for 10 min at 4°C, and resuspended to -2 mg of protein/ml in the same buffer. The membranes were used immediately or stored at -90°C. These membranes were stored up to 8 wk with no significant loss of adenylate cyclase activity, glucagon binding, specific ['5I]iodohydroxybenzylpindolol binding, cholera toxin-catalyzed ADP-ribosylation or activation of adenylate cyclase activity (10) .
Adenylate cyclase assay. Adenylate cyclase activity was assayed in a final volume of 0.1 ml containing 25 mM Tris-HCI, pH 7.5, 5 mM MgCl2, 20 mM creatine phosphate, 100 U/ml creatine phosphokinase, 0.5 mg/ml bovine serum albumin, 1 
RESULTS
Since we had previously demonstrated that the ability of epinephrine, isoproterenol, or glucagon to stimulate glycogen phosphorylase activity was blunted in hepatocytes isolated from triiodothyronine-treated as compared with control rats (26) , it was of interest to investigate the influence of hyperthyroidism on the ability of these glycogenolytic hormones to modulate intracellular cyclic AMP levels ( Fig. 1 ). In the absence of a methyl xanthine, the cyclic AMP response of the hepatocytes stimulated by epinephrine or isoproterenol was relatively small, as previously noted (8, 27) . The cyclic AMP response of the hyperthyroid rat hepatocytes to either isoproterenol or epinephrine was not significantly different from the response in the euthyroid state except at the highest concentration of either hormone where a reduced response in the hyperthyroid rat hepatocytes was evident. In the presence of 50 ,uM methylisobutylxanthine the cyclic AMP responses were potentiated and the blunted maximal response of the hyperthyroid as compared to euthyroid rat hepatocytes to the stimulation by epinephrine or isoproterenol was highlighted (Fig. 1 ). Under these conditions, the stimulation of cyclic AMP accumulation by 10 The stimulation of cyclic AMP accumulation by epinephrine, isoproterenol, or glucagon in hepatocytes isolated from control and triiodothyronine-treated rats. Rat hepatocytes (50 mg cell wet wt/tube) were isolated from euthyroid (control) and hyperthyroid (triiodothyroninetreated) rats, incubated in Krebs-Ringer bicarbonate buffer, pH 7.4, containing 22 mM glucose for 30 min, then resuspended in fresh medium for another 20 min for the experiments. The indicated agents were added 1 min prior to the end of the 20-min incubation and were added in the absence (-MIX) or presence (+MIX) of 50 uM methylisobutylxanthine. At the end of a 1-min incubation with these indicated agents the incubation was terminated and the cyclic AMP accumulation assayed as described. The values provided are mean values±SEM of data derived from at least four separate experiments performed on separate occasions for both control and triiodothyronine-treated rat hepatocytes. Epinephrine (EPI), isoproterenol (ISO), and glucagon were present in the incubation at the final concentrations indicated. Please note different scale for glucagon stimulation in the presence of the methyl xanthine. less in hepatocytes from the triiodothyronine-treated as compared with control rats. Glucagon-stimulated cyclic AMP accumulation was also blunted in the hyperthyroid rat hepatocytes (Fig. 1 ). This impaired response to glucagon in the hyperthyroid state was apparent even when the methyl xanthine was omitted from the incubation (Fig. 1) . Short-term (48 h) administration of triiodothyronine to rats in vivo clearly impairs the ability of catecholamines or glucagon to stimulate cyclic AMP accumulation in hepatocytes isolated from these animals.
The abilities of the potent alpha adrenergic antagonist prazosin and beta adrenergic antagonist propranolol to block catecholamine-stimulated cyclic AMP accumulation was examined in order to probe the nature of the altered adrenergic response noted in the hepatocytes obtained from the triiodothyroninetreated rats (Table I) . Catecholamine-stimulated cyclic AMP accumulation of control rat hepatocytes displayed a beta adrenergic character that was effectively blocked by propranolol but not by prazosin. The inclusion of methylisobutylxanthine in the incubation did not alter the character of the response. The relatively poor cyclic AMP response of the hyperthyroid rat hepatocytes necessitated that the blocking studies be performed in the presence of the methyl xanthine. Under these conditions, catecholamine-stimulated cyclic AMP accumulation by hyperthyroid rat hepatocytes was effectively blocked by propranolol indicating a beta adrenergic nature. Interestingly, prazosin also partially blocked the response of the hyperthyroid rat hepatocytes to epinephrine or isoproterenol. The basis for this observation is unclear.
The blunted cyclic AMP response of the hyperthyroid rat hepatocytes to hormonal stimulation could reflect an increase in cyclic AMP phosphodiesterase activity, a decrease in the number or affinity of hormone receptors coupled to the cyclase, a decrease in the efficiency of transmembrane signaling between the receptors and the cyclase, or some complex modulation of the cyclase system involving several of these loci. Because a linkage between thyroid hormones and cyclic AMP phosphodiesterase activity has been reported in fat cells (28) The hormone-sensitive adenylate cyclase system of the hyperthyroid rat hepatocyte was investigated next, in an attempt to identify the basis for the impaired cyclic AMP response, which apparently did not involve a change in the phosphodiesterase activity. Hepatocytes isolated from control and triiodothyronine-treated rats were homogenized and the hormone-sensitive adenylate cyclase activity measured in the whole homogenate, a crude membrane (pellet-i), and a purified membrane fraction. Hepatocyte yield and the amount of total protein per hepatocyte preparation were not affected by this triiodothyronine treatment (26) . Isoproterenol failed to stimulate adenylate cyclase activity in hyperthyroid rat hepatocyte fractions (Table II) . No (Table II) . Maximal stimulation of the cyclase by glucagon was 50% less in purified membranes from hyperthyroid as compared to euthyroid rat hepatocytes (Fig. 2) . The concentration of glucagon required to achieve half-maximal stimulation of purified membrane adenylate cyclase activity was higher for the hyperthyroid (28±4 nM, n = 5) as compared to euthyroid (7±1 nM, n = 5) rat hepatocyte preparations. These data implicate the hormone-sensitive adenylate cyclase system as the primary site of the impaired hormonal response of the hyperthyroid rat hepatocyte.
The possibility that alterations in hormone receptor status may be an important component of the impaired responses of the hyperthyroid rat hepatocyte was investigated via radioligand binding analysis. Beta adrenergic receptors were studied using the potent antag- fmol/mg protein, n = 4) as compared with control (Bmax = 37±4 fmol/mg protein, n = 4) rat hepatocytes (Fig. 3) . Similar reductions in the amount of specific ['25I]iodohydroxybenzylpindolol binding per milligram of protein were noted in the whole homogenate and low-speed pellet fractions (crude membranes) obtained from the triiodothyronine-treated as compared to control rat hepatocytes (data not shown). A significant increase in the Kd for specific ['25I]iodohydroxybenzylpindolol binding to hepatocyte membranes was noted in the hyperthyroid (Kd = 0.32 ±0.03 nM, n = 4) as compared to the euthyroid (Kd *0.15+0.02 nM, n = 4) states (Fig. 3) . Nonspecific binding was the same for both control and thyroid hormone-treated rat hepatocyte preparations (data not shown).
Specific 1251-glucagon binding to particulate membrane fractions was '50% less in the hyperthyroid as compared in euthyroid rat hepatocyte fractions measured at 0.9, 1.9, or 10.9 nM radioligand (Table III) . Scatchard alytic activity of the cyclase and an indication as to whether the hyperthyroid state might be associated with a change in this parameter. Total fluoride-stimulated adenylate cyclase activity per hepatocyte homogenate was 30% less for the triiodothyronine-treated as compared to euthyroid rat hepatocytes, whereas total protein content was not affected (Table IV) . Fluoride-stimulated activity was 52-55% less in the pellet-1 and purified membrane fractions of the hyperthyroid as compared to euthyroid rat hepatocytes. Although the protein yield of the particulate membrane preparations was reduced in the hyperthyroid rat hepatocyte fractions, it was of insufficient magnitude to explain the loss of catalytic cyclase activity (Table IV) . The ability of guanine nucleotide triphosphates and fluoride to stimulate adenylate cyclase activity in homogenate and purified membrane fractions obtained from control and triiodothyronine-treated rats is shown in Table V . Stimulation of adenylate cyclase by GTP or the guanine nucleotide analogue guanylylimidodiphosphate (GppNHp) was blunted 30-50% in the hepatocyte fraction obtained from the hyperthyroid as compared to euthyroid rat. These data suggest that not only the activation by hormones such as isoproterenol or glucagon but also that the level of activity measured in the presence of either fluoride or GTP are reduced in the hyperthyroid rat hepatocyte. Thus, the reduced hormonal response may reflect alterations in the hormone receptor number, and in either the capacity of the cyclase to utilize a guanine nucleotide triphosphate, or in the amount of catalytic cyclase itself.
It was important to distinguish between a possible reduction in the amount of catalytic cyclase and a reduced amount of adenylate cyclase regulatory proteins necessary for the activation of catalytic cyclase by GTP or fluoride. The regulatory proteins that confer guanine nucleotide, fluoride, and hormone-sensitivity to adenylate cyclase systems replete with hormone receptors and catalytic cyclase are the target for the action of cholera toxin on adenylate cyclase (29) (30) (31) . The Al-subunit of cholera toxin specifically catalyzes ADPribosylation of these regulatory proteins at the expense of NAD+ and irreversibly activates the cyclase activity (cf. 32) . The incubation of hepatocyte homogenate with cholera toxin and NAD+ (1 mM) increased basal and GTP-stimulated adenylate cyclase activity while inhibiting fluoride-activatable activity in a dose-dependent manner (data not shown). Under these conditions, cholera toxin produced maximal effects on the cyclase activity at 30 ,ug/ml. The kinetics of these effects of the in vitro cholera toxin treatment were examined and found to be rapid, achieving near Having demonstrated the ability of cholera toxin to influence the adenylate cyclase system of the rat hepatocyte, we then investigated the effects of toxin treatment on homogenates prepared from hyperthyroid as compared to euthyroid rat hepatocytes (Table  VI) . Cholera toxin increased basal and GTP-stimulated adenylate cyclase activity in hyperthyroid rat hepatocyte preparations, but did not produce the same level of activity noted in the euthyroid rat preparations. Similarly, the difference in fluoride-stimulated activity between the hyperthyroid and euthyroid conditions persisted following the toxin treatment although both were inhibited by the action of cholera toxin (Table VI) Fig. 4 ), but the appearance of this band in autoradiograms from toxin-treated purified membranes was quite variable being nearly absent in some preparations.
The amount of toxin-specific labeling per milligram protein was nearly doubled when the reaction was performed with whole homogenate as compared with purified plasma membrane fractions (data not shown).
In contrast to the single major toxin-specific band of ADP-ribosylation noted with plasma membrane fractions, three heavily labeled bands were evident in autoradiograms of the ADP-ribosylated products from a homogenate fraction (lane D , Fig. 4) . The apparent molecular weights (M,) of these toxin targets as determined under the denaturing, reducing conditions of the electrophoresis were 41.6, 44.4, and 45.9K daltons (average of eight determinations). The 41.6K dalton target is the predominant band when using the homogenate fraction in the toxin-catalyzed reaction. The dose-response with respect to toxin for the cholera toxin-catalyzed ADP-ribosylation of hepatocyte membrane proteins (using the whole homogenate fractions in the reaction) is shown in Fig. 4 , lanes E-L. As was 420 C. C. Malbon and M. L. Greenberg Hepatocytes were isolated from control rats and rats administered 25 usg of triiodothyronine/ 100 g body wt at 48, 24, and 3 h prior to cell isolation. After cell isolation, pellet-1 and purified membrane fractions were prepared as described in Methods. lssI-Glucagon binding was assayed according to the method of Lin et al. (23) . The data are expressed as mean values±SEM from three separate experiments each assayed in triplicate using three different hepatocyte preparations for control and triiodothyronine (T3) treated rats alike. Hepatocytes were isolated from control rats and rats administered 25 Ag of triiodothyronine/100 g body wt at 48, 24 , and 3 h before cell isolation. Protein was assayed according to Lowry et al. (25) and adenylate cyclase was assayed in the presence of 10 mM NaF using the whole homogenate, pellet-I and purified membrane fractions prepared from the isolated hepatocytes. The data are mean values±SEM from three separate hepatocyte preparations for control and triiodothyronine-treated rats alike. P < 0.05 with respect to control activity value. I P < 0.01 with respect to control activity value.
Adenylate Cyclase in Hyperthyroid Rat Hepatocytes It was important to eliminate the possibility that these multiple targets might be generated during the homogenization or in the subsequent steps of the procedure. It was found that the labeling pattern noted in Fig. 5 was not affected when the final membrane pellets were solubilized in SDS/mercaptoethanol and electrophoresed with no boiling, or 1-3 min of boiling. The inclusion of the proteolytic enzyme inhibitor phenylmethanesulfonyl fluoride (0.1 mM) in either the cell homogenization step, or in the toxin-labeling reaction, or both, did not alter this pattern (compare lane H to lane J, Fig. 5 ). Aprotinin and tosyl-L-lysine chloromethyl ketone were similarly without effect on this pattern (data not shown). Exposing liver membranes which had been incubated with [32P]NAD' and cholera toxin to mild proteolysis with trypsin or a-chymotrypsin did not cause the 44.4 or 45.9K dalton band to migrate at the 41.6K dalton region or to any single 30-40K dalton region (data not shown). These data support our hypothesis that there are multiple toxinspecific AD["2P]ribosylated targets in rat hepatocyte membranes that exist in vivo as discrete 45.9, 44.4, and 41.6K dalton entities and that these membrane components may be toxin targets involved in the activation of the cyclase by cholera toxin (presumably representing liver adenylate cyclase regulatory proteins). liquots of whole homogenates (0.7-1.0 mg of protein) were incubated in a final volume of 0.1 ml containing 25 mM Tris-HCI, pH 7.5, 5 mM MgCl2, 20 mM creatine phosphate, 100 U/ml creatine phosphokinase, 0.05 mg bovine serum albumin, 1 mM cyclic AMP, 0.1 mM ascorbic acid, 0.5 mM ATP, 1 mM NAD+, with and without 10 Ag of cholera toxin that was previously activated with 0.5% SDS and 20 mM dithiothreitol (24) . This mixture was incubated for 20 min at 30°C and the incubation stopped by a 20-fold dilution with ice-cold 1 mM NaHCO3 buffer. The contents were then centrifuged at 20,000 g for 15 min at 4°C and the resultant pellet resuspended to a protein concentration of 1 mg/ml with 1 mM NaHCO3 buffer. Adenylate cyclase activity was immediately assayed according to Salomon et al. (15) in the absence or presence of 0.1 mM GTP or 10 mM NaF for a 10-min period at 30'C. The data are expressed as the mean values±SEM from three separate hepatocyte homogenate preparations for euthyroid and hyperthyroid alike. Cholera toxin is abbreviated CT. * P < 0.05 for difference with respect to euthyroid adenylate cyclase values.
The results of our studies of cholera toxin-catalyzed AD[32P]ribosylation of homogenate proteins obtained from hyperthyroid as compared to euthyroid rats are displayed in Fig. 6 . The autoradiograms for hyperthyroid and euthyroid rat hepatocyte homogenates were virtually identical. Scanning densitometry of these autoradiograms failed to identify any significant differences in either the pattern or relative abundance of the toxin-specific ADP-ribosylated proteins in the hyperthyroid as compared with euthyroid rat hepatocyte preparations. The toxin-catalyzed ADP-ribosylation of these rat hepatocyte targets (presumed to be regulatory proteins of adenylate cyclase) appears to be unaltered by the hyperthyroidism induced in these experiments.
The ability of detergent extracts of hepatocyte membranes obtained from euthyroid and hyperthyroid rats to reconstitute the adenylate cyclase of S49 mouse lymphoma cyc-mutant membranes [lacking both functional adenylate cyclase regulatory proteins (34) and toxin-specific labeling products (31) (34) . Incubation of the hepatocyte subcellular fractions and toxin was performed at 30°for 10 min. At the end of the incubation the mixture was diluted 20-fold with cold 250 mM KH2PO4, pH 7.0, buffer, centrifuged, and the resulting pellet solubilized in 1% SDS containing 5% 2-mercaptoethanol and boiled for 3 min. The SDS-polyacrylamide electrophoresis, staining, destaining, and autoradiography are described in Methods.
of the regulatory proteins for adenylate cyclase. Lubrol extracts prepared from hepatocyte membranes were heated at 37°C for 10 (8, 10) . In the present study hyperthyroidism 45.9 kilodaltons (present study). Hyperthyroidism did not alter the pattern or level of these toxin-specific targets for ADP-ribosylation, suggesting that acute hyperthyroidism is not associated with changes in these subunits of the regulatory component of adenylate cyclase. This conclusion was further supported by the finding that Lubrol extracts of purified membranes of control and hyperthyroid rats reconstituted equivalent levels of guanine nucleotide-sensitive adenylate cyclase activity of S49 cyc-mouse lymphoma membranes. These data suggest that the reduced ability of guanine nucleotides to stimulate the adenylate cyclase of hyperthyroid rat hepatocytes is probably a reflection of an alteration in the catalytic moiety and not the regulatory component transducing guanine nucleotide action. Fluoride-sensitive adenylate cyclase activity of the cyc-membranes was significantly lower in the reconstituted system using Lubrol extracts from hyperthyroid as compared with control animals. The impaired response of the hyperthyroid rat hepatocyte cyclase to fluoride stimulation would appear to reflect both the reduction in catalytic cyclase discussed above, and an alteration that involves the ability of the regulatory component to transduce fluoride action to the catalytic cyclase. Thyroid hormones have been shown to influence hormone receptor status in a number of tissues, including as shown in this study, the rat hepatocyte. It is clear from the present study that thyroid hormones may regulate the hormone-sensitive adenylate cyclase system at a number of additional loci such as the regulatory component or catalytic component of the cyclase. The physiological impact of these thyroid hormone-induced alterations on the short-term regulation of hepatic metabolism by hormones is currently being investigated.
